Zymeworks  logo
Zymeworks ZYME
$ 24.12 2.07%

Quarterly report 2022-Q2
added 12-23-2023

report update icon

Zymeworks Total Current Liabilities 2011-2026 | ZYME

Annual Total Current Liabilities Zymeworks

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
71.9 M 85.7 M 82.6 M 30 M - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
85.7 M 30 M 67.5 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer Total Current Liabilities Price % 24h Market Cap Country
ARCA biopharma ARCA biopharma
ABIO
13 M - 1052.0 % $ 415 M usaUSA
Acasti Pharma Acasti Pharma
ACST
1.93 M - 4.01 % $ 150 M canadaCanada
Adverum Biotechnologies Adverum Biotechnologies
ADVM
22.9 M - - $ 86.2 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
5.91 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
58.7 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.78 M - 1.93 % $ 17.4 M usaUSA
I-Mab I-Mab
IMAB
576 M - - $ 866 M chinaChina
Aptorum Group Limited Aptorum Group Limited
APM
4.34 M $ 0.81 0.15 % $ 4.42 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
1.62 B - - $ 40.3 B usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
39.8 M - - $ 3.67 B usaUSA
Albireo Pharma Albireo Pharma
ALBO
45.3 M - -0.23 % $ 916 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
15.7 M - 3.16 % $ 1.9 M usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
1.77 M - -1.52 % $ 24.7 M usaUSA
AlloVir AlloVir
ALVR
5.24 M - 4.14 % $ 49.1 M usaUSA
Akouos Akouos
AKUS
16.8 M - 0.23 % $ 488 M usaUSA
BioVie BioVie
BIVI
2.27 M $ 1.24 -0.8 % $ 1.83 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
2.38 M - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
15.1 M - - $ 10.1 M usaUSA
BioMarin Pharmaceutical BioMarin Pharmaceutical
BMRN
607 M $ 61.58 -1.66 % $ 11.7 B usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
228 M - -24.86 % $ 820 K usaUSA
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
18.6 M $ 4.56 -1.94 % $ 384 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
19 M - 2.71 % $ 14 M usaUSA
Aravive Aravive
ARAV
22.1 M - -13.39 % $ 1.45 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
556 M - - - russiaRussia
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
25.2 M - - $ 26.5 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
816 K - -52.27 % $ 4.45 M usaUSA
Capricor Therapeutics Capricor Therapeutics
CAPR
31.3 M $ 28.24 1.18 % $ 756 M usaUSA
Axsome Therapeutics Axsome Therapeutics
AXSM
379 M $ 165.14 -2.83 % $ 8.22 B usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
7.54 M - - $ 7.46 M israelIsrael
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
13.2 M $ 0.31 -61.59 % $ 42.2 M usaUSA
Atreca Atreca
BCEL
16.3 M - -11.76 % $ 5.79 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
58 M - - $ 2.17 B usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
82.4 M - -4.8 % $ 255 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
20 M $ 12.21 -3.48 % $ 804 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2.21 B - 0.49 % $ 251 B cayman-islandsCayman-islands
Biogen Biogen
BIIB
3.35 B $ 191.78 -1.72 % $ 28.1 B usaUSA
Bellicum Pharmaceuticals Bellicum Pharmaceuticals
BLCM
3.77 M - -9.72 % $ 5.89 M usaUSA
Baudax Bio Baudax Bio
BXRX
21.5 M - 0.59 % $ 63 K usaUSA
Aptose Biosciences Aptose Biosciences
APTO
4.46 M - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
6.29 M - -39.0 % $ 4.57 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
36.9 M - 17.91 % $ 11.1 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
1.13 B $ 14.64 -0.17 % $ 4.52 B usaUSA